MyFinsight
Home
Blog
About
Included within cash and
cash equivalents
$37,355K
(-11.63%↓ Y/Y)
Marketable securities
$13,474K
(79158.82%↑ Y/Y)
Prepaid expenses and
other current assets
$1,351K
(3.92%↑ Y/Y)
Accounts receivable
$790K
(208.59%↑ Y/Y)
Total current assets
$52,970K
(20.81%↑ Y/Y)
Intangible assets, net
$31,700K
(0.00%↑ Y/Y)
Goodwill
$10,672K
(0.00%↑ Y/Y)
Deferred tax asset, net
$5,799K
Property and equipment,
net
$2,517K
(11.62%↑ Y/Y)
Operating lease
right-of-use assets
$1,964K
(8.09%↑ Y/Y)
Deposits and other
long-term assets
$598K
(17.03%↑ Y/Y)
Total assets
$106,220K
(16.98%↑ Y/Y)
Total liabilities and
shareholders equity
$106,220K
(16.98%↑ Y/Y)
Total shareholders
equity
$59,798K
(26.93%↑ Y/Y)
Total liabilities
$46,422K
(6.26%↑ Y/Y)
Noncontrolling deficit
-$1,118K
(12.18%↑ Y/Y)
Lineage's shareholders'
equity
$60,916K
(25.90%↑ Y/Y)
Warrant liabilities
$24,697K
(31.36%↑ Y/Y)
Deferred revenues, net of
current portion
$12,339K
(-3.23%↓ Y/Y)
Total current
liabilities
$8,016K
(-25.47%↓ Y/Y)
Operating lease
liabilities, net of current...
$1,333K
(25.99%↑ Y/Y)
Deferred tax liability,
net
$22K
(-91.94%↓ Y/Y)
Finance lease
liabilities, net of current...
$15K
(-68.75%↓ Y/Y)
Accumulated deficit
-$470,328K
(-7.36%↓ Y/Y)
Accumulated other
comprehensive loss
-$4,473K
(-9.15%↓ Y/Y)
Common shares, no par
value, 450,000 shares...
$535,717K
(9.21%↑ Y/Y)
Accounts payable and
accrued liabilities
$5,387K
(21.03%↑ Y/Y)
Deferred revenues,
current portion
$1,678K
(-68.08%↓ Y/Y)
Operating lease
liabilities, current portion
$918K
(-8.02%↓ Y/Y)
Finance lease
liabilities, current portion
$33K
(-34.00%↓ Y/Y)
Back
Back
Balance Sheet
Lineage Cell Therapeutics, Inc. (LCTX)
Lineage Cell Therapeutics, Inc. (LCTX)
source: myfinsight.com